Volume 39 Issue 04
. 
Turn off MathJax
Article Contents
Abstract
References
Relative Articles
Article Navigation >  Journal of Kunming Medical University  > 2018  >  39(04): 21-26
Zhi YAN, Jingang HAO, Yunyun SHANG. Value of VI-RADS Scoring System in Precision Treatment of Bladder Cancer[J]. Journal of Kunming Medical University, 2022, 43(3): 74-79. doi: 10.12259/j.issn.2095-610X.S20220322
Citation: Hu Feng Di , Zhang Jian Qiang , Wang Chu , Luo Chun Xiang , Li Ke . Influence of CD151 Inhibition by RNAi on Lung Metastasis in Null Mice Given Tail Veins Injection of Lung Adenocarcinoma Cell Lines A549[J]. Journal of Kunming Medical University, 2018, 39(04): 21-26.
shu

Influence of CD151 Inhibition by RNAi on Lung Metastasis in Null Mice Given Tail Veins Injection of Lung Adenocarcinoma Cell Lines A549

Funds:

基金： 云南省教育厅科学研究基金资助项目 (2015Y181); 云南省肿瘤医院博士科研基金资助项目 (BSJJ201506); 普洱学院校级创新团队基金资助项目 (CXTD) ;普洱学院高层次人才科研启动基金资助项目 (K2017051);

  • Received Date: 2017-09-09
    Abstract
  • Objective To explore the influence of CD151 inhibition by RNA interference on lung metastasis in null mice given tail veins injection of lung adenocarcinoma cell lines A549. METHODS: Constructed CD151 inhibition by RNA interference cell lines A549-sh RNA, A549-sh NC and A549-Blank were injected into the tail veins of BALB/c nude mice. Lung metastasis was measured through naked eye and pathology of HE stain. Re s ults Lung metastasis were 62.5% (5/8) and (4.7±1.5) , 100% (7/7) and (9.3±0.8) , 75% (6/8) and (8.2±1.5) , respectively in A549-sh RNA, A549-sh NC and A549-Blank. There were differences between A549-sh RNA and A549-sh NC (P = 0.000) and between A549-sh RNA and A549-Blank (P = 0.006) .Conclus ions Inhibition of CD151 gene expression can reduce lung metastasis in null mice given tail veins injection of lung adenocarcinoma cell lines A549. CD151 may become one of the potential therapeutic targets aiming at inhibitung invasion and metastasis of NSCLC.
    • FullText(HTML)
    • References(12)
  • [1]石远凯, 孙燕, 于金明, 等.中国晚期原发性肺癌诊治专家共识 (2016年版) [J].中国肺癌杂志, 2016, 18 (01) :1-15.
    [2]
    [2]SADEJ R, GRUDOWSKA A, TURCZYK L, et al.CD151in cancer progression and metastasis:A complex scenario[J].Lab Invest, 2014, 94 (1) :41-51.
    [3]李科, 洪志鹏, 李云霞, 等.非小细胞肺癌组织CD151蛋白表达临床意义探讨[J].中华肿瘤防治杂志, 2014, 22 (01) :34-38.
    [4]李科, 洪志鹏, 沈丽达, 等.CD_ (151) 及整合素α_3β_1蛋白在非小细胞肺癌中的表达及意义[J].中国全科医学, 2014, 16 (05) :531-535.
    [5]
    [5]LI P, ZENG H, QIN J, et al.Effects of tetraspanin CD151inhibition on A549 human lung adenocarcinoma cells[J].Mol Med Rep, 2015, 11 (2) :1258-1265.
    [6]
    [6]KUMARI S, DEVI G T, BADANA A, et al.CD151-A Striking Marker for Cancer Therapy[J].Biomark Cancer, 2015, 22 (7) :7-11.
    [7]
    [7]LIU T, WANG S, WANG L, et al.Targeting CD151 by lentivirus-mediated RNA interference inhibits luminal and basal-like breast cancer cell growth and invasion[J].Mol Cell Biochem, 2015, 407 (1-2) :111-121.
    [8]
    [8]ZHANG Z, WANG F, LI Q, et al.CD151 knockdown inhibits osteosarcoma metastasis through the GSK-3beta/beta-catenin/MMP9 pathway[J].Oncol Rep, 2016, 35 (3) :1764-1770.
    [9]
    [9] AZNAVOORIAN S, MURPHY A N, STETLERSTEVENSON W G, et al.Molecular aspects of tumor cell invasion and metastasis[J].Cancer, 1993, 71 (4) :1368-1383.
    [10]
    [10]FIDLER I J.Critical determinants of metastasis[J].Semin Cancer Biol, 2002, 12 (2) :89-96.
    [11]
    [11]TAKEDA Y, LI Q, KAZAROV A R, et al.Diminished metastasis in tetraspanin CD151-knockout mice[J].Blood, 2011, 118 (2) :464-472.
    [12]
    [12]COPELAND B T, BOWMAN MJ, ASHMAN L K.Genetic ablation of the tetraspanin CD151 reduces spontaneous metastatic spread of prostate cancer in the TRAMP model[J].Mol Cancer Res, 2013, 11 (1) :95-105.
    • Relative Articles(20)

  • Relative Articles

    [1] Shengxi YANG, Jiade ZHU, Qiurui LI, Wenlian TU. Clinical Study of Aumolertinib Versus Osimertinib in the Treatment of EGFR-Mutated Advanced Non-Small Cell Lung Cancer. Journal of Kunming Medical University, 2025, 46(5): 1-7.
    [2] Huimin YU, Xin XIN, Zhiwei LIANG. Predictive Value of KIAA1199 and Linc00673 Genes on Chemotherapy Efficacy in Non-small Cell Lung Cancer. Journal of Kunming Medical University, 2025, 46(1): 111-116.  doi: 10.12259/j.issn.2095-610X.S20250115
    [3] Yingfu LI, Ni GUO, Zhengguang LUO, Anhao XING, Taifu LI, Qianli MA. Correlation of EGFR Gene Polymorphisms with Non-small Cell Lung Cancer in Yunnan Han Population. Journal of Kunming Medical University, 2025, 46(4): 1-11.
    [4] Chao HONG, Xudong XIANG, Yingfu LI, Yang CAO, Xueya CHEN, Shuai LI, Anhao XING, Mu LIN, Qianli MA. Association of Polymorphisms in the 3' UTR of Genes in the ERK1/2 Signaling Pathway with Non-small Cell Lung Cancer. Journal of Kunming Medical University, 2024, 45(3): 7-17.  doi: 10.12259/j.issn.2095-610X.S20240302
    [5] Caini ZHANG, Ya LI. A Meta-analysis of the Efficacy and Safety of Camrelizumab Combined with Chemotherapy in the Treatment of Non-small Cell Lung Cancer. Journal of Kunming Medical University, 2024, 45(6): 75-84.  doi: 10.12259/j.issn.2095-610X.S20240610
    [6] Yan LIANG, Lei WANG, Ming LEI, Benchao CHEN, Ping SUN, Shuai LI, Li LIU, Qianrong WANG, Manlin LIAO, Qianli MA. Correlation between KRAS Gene Polymorphism and Non-small Cell Lung Cancer in Yunnan Han Population. Journal of Kunming Medical University, 2023, 44(2): 52-60.  doi: 10.12259/j.issn.2095-610X.S20230210
    [7] Chuntao LI, Xuemei ZHANG, Yandi SU, Jianqing Zhang. Construction of Stable Transfected Cell Line A549 of Non-small Cell Lung Cancer by Overexpressing and Knocking Down LncRNA RP11-521C20.3. Journal of Kunming Medical University, 2023, 44(10): 1-9.  doi: 10.12259/j.issn.2095-610X.S20231016
    [8] Jia YANG, Ya-xian LI, Ying-ying WANG, Lin XIAO, Chuan-yin LI, Fang TAN, Qian-li MA, Shu-yuan LIU. Association of the miR-149,miR-219 and miR-let-7 Polymorphisms with the Occurrence and Development of Non-small Cell Lung Cancer in a Chinese Han Population in Yunnan Province. Journal of Kunming Medical University, 2021, 42(10): 22-28.  doi: 10.12259/j.issn.2095-610X.S20211037
    [9] Ying-xia WANG, Qin HE, Guo-fang WANG, Xuan ZHANG. Expression and Significance of microRNA-21 and EGFR in Non-small Cell Lung Cancer. Journal of Kunming Medical University, 2021, 42(8): 101-105.  doi: 10.12259/j.issn.2095-610X.S20210818
    [10] Chen Ben Chao , Li Heng , Liu Chao , Wang Shu Ting , Li Gao Feng . . Journal of Kunming Medical University, 2020, 41(06): 23-27.
    [11] Wang Juan , Su Guo Miao , Pan Guo Qing , Bian Li , Yang Zhe , Zeng Ding Tao . . Journal of Kunming Medical University, 2020, 41(09): 1-6.
    [12] Xiao-biao MA, Feng LUO, Yong-liang GAO, Jing-chao HAO. Clinical Study of Chemotherapy Combined with CIK Cell Immunotherapy for Non-small Cell Lung Cancer. Journal of Kunming Medical University, 2020, 41(12): 60-67.  doi: 10.12259/j.issn.2095-610X.S20201215
    [13] Tang Shi Cong , Pan Hong , Huang Yao Yuan , Zhou Xin , Wang Shou Feng , Zuo Chuan Tian , Mao Nai Quan . . Journal of Kunming Medical University, 2017, 38(02): 28-32.
    [14] Chen Yan Jin . . Journal of Kunming Medical University,
    [15] Zhou JieYan . . Journal of Kunming Medical University,
    [16] . Thoracoscopic Lobectomy in the Treatment of 54 Patients with Non-small Cell Lung Cancer. Journal of Kunming Medical University,
    [17] . Relationship between Expression of CDK2 and p27kip1 Protein and Non-small Cell Lung Cancer in Xuanwei. Journal of Kunming Medical University,
    [18] . Clinical Effects of Double-way Chemotherapy on Non-small Cell Lung Cancer with Malignant Pericardial Effusion. Journal of Kunming Medical University,
    [19] Yang Fang . . Journal of Kunming Medical University,
    [20] Zhang Lan Feng . . Journal of Kunming Medical University,
    • Supplements(0)
    • Cited By

  • Cited by

    Periodical cited type(4)

    1. 褚雨露，孟庆涛. 多参数磁共振VI-RADS在膀胱癌病理分级及肌层浸润中的诊断价值. 中国CT和MRI杂志. 2024(05): 140-142 .
    2. 褚雨露，孟庆涛，王雪强，陆玉和. VI-RADS评分对膀胱癌肌层浸润的诊断价值研究. 中国临床新医学. 2023(01): 73-76 .
    3. 李祥孟，曾繁浩，唐振华，倪茂，夏成兴，杨德林，王剑松，颜汝平. 荧光膀胱镜在尿路上皮膀胱癌中的诊断价值. 现代肿瘤医学. 2023(14): 2699-2702 .
    4. 孟庆涛，李军，蒋会东，王雪强，相丽. VI-RADS联合IVIM序列在膀胱癌肌层侵犯评估中的价值. 中华全科医学. 2022(12): 2096-2100 .

    Other cited types(2)

  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-040
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 27.3 %FULLTEXT: 27.3 %META: 72.1 %META: 72.1 %PDF: 0.6 %PDF: 0.6 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 4.4 %其他: 4.4 %China: 4.2 %China: 4.2 %Taichung: 0.0 %Taichung: 0.0 %上海: 6.1 %上海: 6.1 %东莞: 0.1 %东莞: 0.1 %丽水: 0.0 %丽水: 0.0 %九江: 0.0 %九江: 0.0 %六安: 0.1 %六安: 0.1 %内华达: 0.0 %内华达: 0.0 %北京: 20.6 %北京: 20.6 %南宁: 0.0 %南宁: 0.0 %呼和浩特: 0.0 %呼和浩特: 0.0 %哈尔滨: 0.0 %哈尔滨: 0.0 %哥伦布: 0.0 %哥伦布: 0.0 %大连: 0.0 %大连: 0.0 %安康: 0.0 %安康: 0.0 %安阳: 0.0 %安阳: 0.0 %宣城: 0.1 %宣城: 0.1 %广州: 0.1 %广州: 0.1 %廊坊: 0.0 %廊坊: 0.0 %张家口: 0.0 %张家口: 0.0 %无锡: 0.2 %无锡: 0.2 %昆明: 0.2 %昆明: 0.2 %晋城: 0.0 %晋城: 0.0 %朝阳: 0.0 %朝阳: 0.0 %杭州: 0.1 %杭州: 0.1 %武汉: 0.1 %武汉: 0.1 %波士顿: 0.0 %波士顿: 0.0 %济南: 0.0 %济南: 0.0 %深圳: 0.2 %深圳: 0.2 %漳州: 0.1 %漳州: 0.1 %盐城: 0.1 %盐城: 0.1 %石家庄: 0.1 %石家庄: 0.1 %福州: 0.0 %福州: 0.0 %秦皇岛: 0.0 %秦皇岛: 0.0 %绍兴: 0.0 %绍兴: 0.0 %芒廷维尤: 1.1 %芒廷维尤: 1.1 %襄阳: 0.0 %襄阳: 0.0 %西宁: 2.9 %西宁: 2.9 %西安: 0.1 %西安: 0.1 %贵阳: 0.0 %贵阳: 0.0 %赤峰: 0.1 %赤峰: 0.1 %运城: 0.2 %运城: 0.2 %邯郸: 0.0 %邯郸: 0.0 %郑州: 0.5 %郑州: 0.5 %重庆: 0.1 %重庆: 0.1 %长沙: 0.1 %长沙: 0.1 %马鞍山: 0.0 %马鞍山: 0.0 %驻马店: 58.0 %驻马店: 58.0 %其他ChinaTaichung上海东莞丽水九江六安内华达北京南宁呼和浩特哈尔滨哥伦布大连安康安阳宣城广州廊坊张家口无锡昆明晋城朝阳杭州武汉波士顿济南深圳漳州盐城石家庄福州秦皇岛绍兴芒廷维尤襄阳西宁西安贵阳赤峰运城邯郸郑州重庆长沙马鞍山驻马店

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (2253) PDF downloads(97) Cited by(6)
    Proportional views
    Related

    Copyright © 《昆明医科大学学报》编辑部  滇ICP备00000000号-0

    Publishing: 昆明医科大学学报编辑部

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return